BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25/04/2016

FDA Clears Path for Chlorthalidone Tablets

The FDA has determined that 15mg chlorthalidone tablets were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of generic versions of the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →